Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

”Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Greece Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems,Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the Greece Drug Delivery Devicesmarket.
- Key players covered include GlaxoSmithKline plc, Baxter International Inc., Boehringer Ingelheim GmbH, AstraZeneca PLC, Hospira, Inc., Medtronic, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Greece Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Drug Delivery Devices In Greece 10
3.1 Drug Delivery Devices, Greece, Overall Revenue ($m), 2003-2017 10
3.2 Drug Delivery Devices, Greece, Category Volume (Units), 2003-2017 16
3.3 Drug Delivery Devices, Greece, Company Share (2009-2010) 21
4 Central Venous Catheters In Greece 23
4.1 Central Venous Catheters Overall Revenue (2003-2017) 23
4.2 Central Venous Catheters Overall Volume (2003-2017) 26
4.3 Central Venous Catheters Average Price (2003-2017) 29
4.4 Central Venous Catheters Distribution Share (2009-2010) 30
4.5 Central Venous Catheters, Greece, Company Share (2009-2010) 31
5 Infusion Systems In Greece 33
5.1 Infusion Systems Overall Revenue (2003-2017) 33
5.1.1 Syringe Pumps Revenue (2003-2017) 37
5.1.2 Ambulatory Infusion Pumps Revenue (2003-2017) 39
5.2 Infusion Systems Overall Volume (2003-2017) 43
5.2.1 Syringe Pumps Volume (2003-2017) 47
5.2.2 Ambulatory Infusion Pumps Volume (2003-2017) 50
5.3 Infusion Systems Average Price (2003-2017) 53
5.4 Infusion Systems Distribution Share (2009-2010) 54
5.5 Infusion Systems, Greece, Company Share (2009-2010) 55
6 Metered Dose Inhaler Devices In Greece 57
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 57
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 60
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 62
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 63
6.5 Metered Dose Inhaler Devices, Greece, Company Share (2009-2010) 64
7 Needle Free Injections In Greece 66
7.1 Needle Free Injections Overall Revenue (2003-2017) 66
7.2 Needle Free Injections Overall Volume (2003-2017) 68
7.3 Needle Free Injections Average Price (2003-2017) 70
7.4 Needle Free Injections Distribution Share (2009-2010) 71
7.5 Needle Free Injections, Greece, Company Share (2009-2010) 72
8 Overview of Key Companies in Greece Drug Delivery Devices Market 74
8.1 GlaxoSmithKline plc 74
8.1.1 Company Overview 74
8.2 Baxter International Inc. 74
8.2.1 Company Overview 74
8.3 Boehringer Ingelheim GmbH 74
8.3.1 Company Overview 74
8.4 AstraZeneca PLC 75
8.4.1 Company Overview 75
8.5 Hospira, Inc. 75
8.5.1 Company Overview 75
8.6 Medtronic, Inc. 75
8.6.1 Company Overview 75
8.7 Fresenius Kabi AG 76
8.7.1 Company Overview 76
8.8 CareFusion Corporation 76
8.8.1 Company Overview 76
8.9 B. Braun Melsungen AG 76
8.9.1 Company Overview 76
8.10 Terumo Corporation 77
8.10.1 Company Overview 77
8.11 Smiths Medical 77
8.11.1 Company Overview 77
8.12 Teleflex Incorporated 77
8.12.1 Company Overview 77
8.13 Codman & Shurtleff, Inc. 78
8.13.1 Company Overview 78
8.14 Becton, Dickinson and Company 78
8.14.1 Company Overview 78
8.15 Consort Medical plc 78
8.15.1 Company Overview 78
8.16 Edwards Lifesciences Corporation 79
8.16.1 Company Overview 79
8.17 3M Health Care 79
8.17.1 Company Overview 79
8.18 INJEX - Equidyne Systems 79
8.18.1 Company Overview 79
8.19 Antares Pharma, Inc. 80
8.19.1 Company Overview 80
8.20 Bioject Medical Technologies Inc. 80
8.20.1 Company Overview 80
9 Appendix 81
9.1 Global Markets Direct Research Methodology 81
9.2 Definitions of Markets Covered in the Report 82
9.2.1 Drug Delivery Devices 82
9.3 Secondary Research 84
9.4 Primary Research 85
9.5 Models 85
9.6 Forecasts 86
9.7 Expert Panel Validation 86
9.8 Currency Conversion 86
9.9 Contact Us 87
9.10 Disclaimer 87